Federal Register: December 30, 2002 (Volume 67, Number 250)
DOCID: FR Doc 02-32812
DEPARTMENT OF DEFENSE
Army Department
NOTICE: NOTICES
ACTION: Patent licenses; non-exclusive, exclusive, or partially exclusive:
DOCUMENT ACTION: Notice.
SUBJECT CATEGORY:
Intent To Grant an Exclusive License of a U.S. Government-Owned Patent
DATES: File written objections by January 14, 2003.
DOCUMENT SUMMARY:
In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(I)(i), announcement is made of the intent to grant an exclusive, royalty bearing, revocable license to U.S. patent number 6,387,665 issued May 14, 2002 entitled ``Method of Making a Vaccine for Anthrax,'' and U.S. patent number 6,316,006 issued November 13, 2001 entitled ``Asporogenic B. Anthracis Expression System'' to VaxGen, Inc. with its principal place of business at 1000 Marina Blvd., Suite 200, Brisbane, Ca 94005. The exclusive field of use will be in field of preventive vaccines against anthrax infection.
SUMMARY:
Method of making vaccine for anthrax,
SUPPLEMENTAL INFORMATION
Anyone wishing to object to the grant of
this license can file written objections along with supporting
evidence, if any, within 15 days from the date of this publication.
Written objections are to be filed with the Command Judge Advocate (see addresses).
Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 0232812 Filed 122702; 8:45 am]
BILLING CODE 371008M
FOR FURTHER INFORMATION CONTACT
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 6197808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 6196664, both at telefax (301) 6195034.